Amphastar Pharmaceuticals(AMPH) Stock Price Today

US Stock MarketDetailed Quotes

AMPH Amphastar Pharmaceuticals

Watchlist

25.100
-1.510-5.67%

Trading Apr 7 12:26 ET

1.20BMarket Cap8.20P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

We Think Amphastar Pharmaceuticals (NASDAQ:AMPH) Can Stay On Top Of Its Debt
Simply Wall StApr 4 11:19 ET
Amphastar Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference
AccesswireApr 3 06:00 ET
Insider Sale: Director at $AMPH Sells 500 Shares
Quiver QuantitativeApr 2 19:01 ET
International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award
AccesswireMar 28 06:00 ET
Hospital Stocks Are Ready to Rebound, Deutsche Bank Says
BNN BloombergMar 25 13:51 ET
Proposed Medicaid Cuts Would Devastate Local Economies: Report -- Barrons.com
Barron'sMar 25 00:01 ET

Comments

Teddy123

Mar 28 18:17

International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award

$Amphastar Pharmaceuticals (AMPH.US)$
Amphastar Wins FDA Award: How Its Solution to Critical Drug Shortage Signals Major Growth

Analysts Notebook

Sep 5, 2024 19:06

Columns 'Trump Trade' vs. 'Harris Trade': How They Could Shape Your Portfolio

The 2024 U.S. presidential race between former President Donald Trump and current Vice President Kamala Harris is still "incredibly close," according to the latest New York Times survey. As investors await the outcome of the November election, equity analysts are busy parsing through the candidates' pronouncements for clues on which stocks could benefit from their policies.
Jefferies analysts cited 10 possible policies that Tr...

Trump trade: Bitcoin hit record highs and Tesla hits $1 trillion market cap

Meltyy

May 23, 2024 22:18

$Amphastar Pharmaceuticals (AMPH.US)$ 📣 Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol
✨Bioequivalent and therapeutically equivalent to $TEVA ProAir® HFA Inhalation Aerosol
» ANDA approval
» Indication: Tx or prevention of bronchospasm 🫁
» Product launch in Q3 '24

Moomoo AI

Jan 20, 2024 03:36

The market's growth expectations seem moderated as EPS growth outpaces average annual share price increase. The recent rise in total shareholder return could suggest business improvement over time.

Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Performs Better Than Its Underlying Earnings Growth Over Last Three Years

Moomoo AI

Dec 20, 2023 19:52

The impressive EPS growth and large insider ownership make Amphastar Pharmaceuticals a potentially attractive investment. The business appears to have reached a growth inflection point.

If EPS Growth Is Important To You, Amphastar Pharmaceuticals (NASDAQ:AMPH) Presents An Opportunity

Explore moomoo's "Insider Activity" for institutional sentiment

AMPH Amphastar Pharmaceuticals

Trade Overview

Capital Trend

News

Comments

Market Insights

Latest News

Investment Course

Discussing

Monetary Policy: Navigating the Fed's Rate Cut Cycle